Archive for December 2020
Philips to Acquire BioTelemetry in $2.8B Deal
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that they have entered into a definitive merger agreement with Royal Philips (NYSE: PHG, AEX: PHIA). Royal Philips, a global leader in health technology, and BioTelemetry, Inc., a…
Read MoreMiach Orthopaedics’ ACL Tear Device Granted FDA De Novo Approval
Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that the U.S. Food & Drug Administration has granted the company’s De Novo Request for the Bridge-Enhanced® ACL Repair (BEAR®) Implant, resulting in marketing approval for the treatment of anterior cruciate ligament (ACL) tears, one of the…
Read MorePhilips and Insightec Teaming Up on Ultrasound for Neurosurgery
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and InSightec, a global healthcare company focused on the therapeutic power of acoustic energy, today announced a collaboration to expand access to MR-guided focused ultrasound for incisionless neurosurgery. By developing compatibility between Philips’ advanced MR systems and the Exablate Neuro platform from InSightec, the two…
Read MoreIntegra LifeSciences to Acquire ACell for $300M
Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc. (“ACell”) for an upfront cash payment of $300 million at closing, subject to customary purchase price adjustments, and cash payments of up to an additional $100 million upon the achievement of certain…
Read MoreSoniVie Receives FDA Breakthrough Device Designation for Therapeutic Intravascular Ultrasound
SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, today announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the TIVUS System for renal artery denervation for the treatment of resistant hypertension, which is defined…
Read MoreVolta Medical Receives FDA Clearance for AI Cardiac Electrophysiology Software
Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time…
Read MoreOlympus Buys Veran Technologies for $340M
Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas (OCA) and will be the latest in a…
Read MoreNeuroOne Medical Announces First Human Commercial Use of its Evo Cortical Electrode at Mayo Clinic
NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the first human commercial use of its Evo Cortical Electrode at Mayo Clinic in Rochester, Minnesota. The procedure was performed by Jamie Van Gompel, M.D., from November 23rd through November 27th on a patient that had…
Read MoreZimmer Biomet Picks up Chest Surgery Toolmaker A&E Medical for $250M
Vance Street Capital LLC (“Vance Street”) is pleased to announce it has completed the sale of A&E Medical Corporation (“A&E Medical”) to Zimmer Biomet (NYSE: ZBH) (“Zimmer”), a global leader in musculoskeletal healthcare, for $250 million. The transaction marks the second exit out of Vance Street’s Sophomore Fund. Founded in 1968 and headquartered in Farmingdale,…
Read More